Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients
Pharmaceutical Business Review
Tue, 03/22/22 - 10:41 am
Merck
Keytruda
endometrial cancer
FDA
Merck fights back against Roche in adjuvant lung cancer therapy
Pharmaforum
Fri, 03/18/22 - 10:54 am
Merck
Keytruda
non-small cell lung cancer
clinical trials
Roche
Tecentriq
Merck Announces Ups and Downs Involving Blockbuster Keytruda
BioSpace
Tue, 03/15/22 - 11:39 pm
Merck
Keytruda
Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy
Fierce Biotech
Mon, 03/7/22 - 11:01 pm
Alpine Immune Sciences
davoceticept
Merck
Keytruda
clinical trials
patient deaths
Deaths in Keytruda combo study spur Celyad to pause trial of off-the-shelf CAR-T cell therapy
Fierce Biotech
Mon, 02/28/22 - 11:24 am
Celyad Oncology
CAR-T
clinical trials
Keytruda
CYAD-101
colorectal cancer
'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff
Endpoints
Fri, 02/4/22 - 11:13 am
Merck
Pharma CEOs
Rob Davis
M&A
Keytruda
patent cliff
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic
Fierce Biotech
Thu, 01/27/22 - 11:38 pm
HIV
Merck
Keytruda
Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC
Endpoints
Wed, 01/19/22 - 10:59 am
Merck
Keytruda
liver cancer
HCC
Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda
Pharmaforum
Tue, 01/11/22 - 11:28 am
Merck
Roche
Keytruda
clinical trials
non-small cell lung cancer
Tecentriq
Immuno-oncology spotlight falls on cervical cancer
EP Vantage
Tue, 12/7/21 - 10:39 am
immuno-oncology
cervical cancer
Opdivo
Keytruda
Bristol Myers Squibb
Merck
Keytruda wins eighth FDA approval of 2021, moving into adjuvant and pediatric melanoma settings
Endpoints
Mon, 12/6/21 - 10:57 am
Merck
Keytruda
melanoma
adolescents
Go or no go? Argenx's December showdown
EP Vantage
Wed, 12/1/21 - 10:10 am
FDA
Argenx
efgartigimod
myasthenia gravis
Calliditas
Nefcon
Merck
Keytruda
Merck's Keytruda scores first win in adjuvant kidney cancer, giving it a leg up on checkpoint inhibitor rivals
Endpoints
Thu, 11/18/21 - 10:37 am
Merck
Keytruda
adjuvant immunotherapy
renal cell carcinoma
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck
Endpoints
Mon, 11/8/21 - 10:58 am
Bristol Myers Squibb
Merck
Opdivo
lung cancer
Keytruda
Merck's Keytruda close to becoming top-selling drug in the world
Beckers Hospital Review
Mon, 11/1/21 - 10:39 am
Merck
Keytruda
AbbVie
Humira
drug sales
Gilead, Merck to study combination therapy for breast cancer
Pharmaceutical Business Review
Fri, 10/29/21 - 10:56 am
Gilead Sciences
Merck
Trodelvy
Keytruda
triple negative breast cancer
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Merck
Keytruda
Xeris Biopharma
XeriJect
Evaxion Biotech
EVX-01
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
Merck carves out path in first-line advanced cervical cancer with new FDA win for Keytruda juggernaut
Endpoints
Wed, 10/13/21 - 10:48 pm
Merck
Keytruda
FDA
cervical cancer
Is an Acquisition of Acceleron a Smart Move for Merck?
Motley Fool
Fri, 10/8/21 - 10:35 am
Merck
M&A
Acceleron
PAH
Keytruda
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »